Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Advanced Technologies
16%
Associated Complications
16%
Autopsy Specimens
16%
Clinical Practice
16%
Clinical Practice Guidelines
100%
Clinician Educator
33%
COVID-19
33%
Curriculum Design
33%
Curriculum Renewal
33%
Direct Sampling
16%
Disease Progression
16%
Disease States
16%
Disease-modifying Agents
16%
Glomerular Disease
33%
IgA Nephropathy (IgAN)
83%
Immunoglobulin A Vasculitis
66%
Interprofessional Education
33%
Kidney Biopsy
33%
Kidney Disease Outcomes Quality Initiative (KDOQI)
100%
Kidney Disease: Improving Global Outcomes (KDIGO)
100%
Kidney Tissue
33%
Lessons Learned
16%
Management Strategies
16%
Mechanism of Action
16%
Multivariate Analysis
16%
Native Kidney
16%
Nephrology
50%
Novel Therapeutics
33%
Oxford Classification
33%
Oxford Classification of IgA Nephropathy
33%
Prognostic Value
25%
Progressive Renal Disease
16%
Renal Biopsy
33%
Renewal Process
16%
Retrospective Analysis
33%
Risk Stratification
16%
School of Medicine
33%
Social Media
33%
Specific Diagnosis
16%
Therapeutic Mechanism
16%
Tissue Adequacy
16%
Tissue Staining
16%
Transitional Care
33%
Transplant Kidney
16%
Treatment Options
16%
Tubulointerstitial Fibrosis
16%
United States
23%
University of Washington
33%
University Schools
33%
Urine Studies
16%
Medicine and Dentistry
Biopsy Technique
16%
Clinical Significance
8%
Clinician
8%
Creatinine
8%
Disease Exacerbation
9%
Diseases
60%
End Stage Renal Disease
8%
Fibrosis
8%
Focal Segmental Glomerulosclerosis
8%
Glomerulonephritis
16%
Glomerulopathy
16%
Hazard Ratio
8%
Idiopathic Pulmonary Fibrosis
8%
Immunoglobulin A
66%
Immunoglobulin A Nephropathy
100%
Immunosuppressive Therapy
16%
Kidney Function
8%
Kidney Graft
8%
Kidney Tissue
16%
Morbidity
8%
Multivariate Analysis
16%
Nephrology
8%
Nephropathy
91%
Pathophysiology
9%
Proteinuria
8%
Renal Biopsy
33%
Retrospective Study
8%
Risk Stratification
9%
Targeted Therapy
16%
Treatment Option
9%
Vasculitis
66%
